DEF 14A
DEFINITIVE PROXY STATEMENT
- Company
- HERON THERAPEUTICS, INC. /DE/
- Filed
- June 3, 2011
- Period of Report
- June 29, 2011
- Accession Number
- 0001193125-11-158564
A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →